Carol A Lange
Carol A. Lange, Ph.D. is Professor of Medicine and Pharmacology, Tickle Family Land Grant Endowed Chair in Breast Cancer Research, and Director, Cell Signaling Program, University of Minnesota Masonic Cancer Center, Minneapolis, MN. Dr. Lange joined the University of Minnesota (Dept. of Medicine) faculty in 1999. Her research is focused on steroid hormone action in breast cancer progression. Her lab studies the role of cross-talk between growth factor-mediated signaling pathways and steroid hormone receptors, using the human progesterone receptor as a model receptor. Additional research focus is aimed at understanding the role of breast tumor kinase (PTK6/Brk) upstream of stress-activated signaling pathways (p38 MAPK and ERK5) that mediate advanced stages of breast cancer progression (invasion and metastasis). Dr. Lange has published over 70 peer-reviewed papers and invited reviews. She is the Director of a Cancer Biology Training Grant (T32) within the Masonic Cancer Center. Dr. Lange is Editor-In-Chief of the journal Hormones and Cancer, and has served on numerous regional and national study sections; she was a charter member of the Molecular Oncogenesis (MONC) NIH study section and currently serves as a standing member of the Molecular and Cellular Endocrinology (MCE) NIH study section.
Abstracts this author is presenting: